PFIZER INC Goodwill, Other Changes (Deprecated 2016-01-31)
PFIZER INC (PFE) reported Goodwill, Other Changes (Deprecated 2016-01-31) of $575.00 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-27.
Discontinued › Notes › Intangible Assets
us-gaap:GoodwillOtherChanges · last filed 2015-02-27
- PFIZER INC goodwill, other changes (deprecated 2016-01-31) for the quarter ending 2014-12-31 was $656.00M.
- PFIZER INC goodwill, other changes (deprecated 2016-01-31) for the quarter ending 2014-09-28 was $61.00M, a 96.77% increase year-over-year.
- PFIZER INC goodwill, other changes (deprecated 2016-01-31) for the quarter ending 2014-06-29 was -$194.00M, a 166.90% decline year-over-year.
- PFIZER INC goodwill, other changes (deprecated 2016-01-31) for the quarter ending 2014-03-30 was $52.00M, a 91.98% decline year-over-year.
- PFIZER INC goodwill, other changes (deprecated 2016-01-31) for fiscal 2014 was $575.00M, a 32.35% decline from fiscal 2013.
- PFIZER INC goodwill, other changes (deprecated 2016-01-31) for fiscal 2013 was $850.00M, a 43.82% decline from fiscal 2012.
- PFIZER INC goodwill, other changes (deprecated 2016-01-31) for fiscal 2012 was $1.51B, a 355.72% increase from fiscal 2011.
- PFIZER INC goodwill, other changes (deprecated 2016-01-31) for fiscal 2011 was $332.00M, a 51.39% decline from fiscal 2010.
| Period end | Goodwill, Other Changes (Deprecated 2016-01-31) 3 month | Goodwill, Other Changes (Deprecated 2016-01-31) 6 month | Goodwill, Other Changes (Deprecated 2016-01-31) 9 month | Goodwill, Other Changes (Deprecated 2016-01-31) 12 month | Goodwill, Other Changes (Deprecated 2016-01-31) 12 month as first filed |
|---|---|---|---|---|---|
| 2014-12-31 | $656.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $717.00M derived: sum of 2 quarters · filed 2015-02-27 | $523.00M derived: sum of 3 quarters · filed 2015-02-27 | $575.00M 10-K · filed 2015-02-27 | |
| 2014-09-28 | $61.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$133.00M derived: sum of 2 quarters · filed 2014-11-06 | -$81.00M 10-Q · filed 2014-11-06 | -$200.00M derived: sum of 4 quarters · filed 2015-02-27 | |
| 2014-06-29 | -$194.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$142.00M 10-Q · filed 2014-08-07 | -$261.00M derived: sum of 3 quarters · filed 2015-02-27 | -$230.00M derived: sum of 4 quarters · filed 2015-02-27 | |
| 2014-03-30 | $52.00M 10-Q · filed 2014-05-08 | -$67.00M derived: sum of 2 quarters · filed 2015-02-27 | -$36.00M derived: sum of 3 quarters · filed 2015-02-27 | $254.00M derived: sum of 4 quarters · filed 2015-02-27 | |
| 2013-12-31 | -$119.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$88.00M derived: sum of 2 quarters · filed 2015-02-27 | $202.00M derived: sum of 3 quarters · filed 2015-02-27 | $850.00M 10-K · filed 2015-02-27 | |
| 2013-09-29 | $31.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $321.00M derived: sum of 2 quarters · filed 2013-11-08 | $969.00M 10-Q · filed 2013-11-08 | $1.89B derived: sum of 4 quarters · filed 2014-02-28 | |
| 2013-06-30 | $290.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $938.00M 10-Q · filed 2013-08-09 | $1.85B derived: sum of 3 quarters · filed 2014-02-28 | $2.07B derived: sum of 4 quarters · filed 2014-02-28 | |
| 2013-03-31 | $648.00M 10-Q · filed 2013-05-10 | $1.56B derived: sum of 2 quarters · filed 2014-02-28 | $1.78B derived: sum of 3 quarters · filed 2014-02-28 | $1.99B derived: sum of 4 quarters · filed 2014-02-28 | |
| 2012-12-31 | $917.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $1.13B derived: sum of 2 quarters · filed 2014-02-28 | $1.34B derived: sum of 3 quarters · filed 2014-02-28 | $1.51B 10-K · filed 2014-02-28 | $502.00M 10-K · filed 2013-02-28 |
| 2012-09-30 | $213.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $420.00M derived: sum of 2 quarters · filed 2012-11-09 | $596.00M 10-Q · filed 2012-11-09 | $1.58B derived: sum of 4 quarters · filed 2013-02-28 | |
| 2012-07-01 | $207.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $383.00M 10-Q · filed 2012-08-09 | $1.37B derived: sum of 3 quarters · filed 2013-02-28 | $327.00M derived: sum of 4 quarters · filed 2013-02-28 | |
| 2012-04-01 | $176.00M 10-Q · filed 2012-05-10 | $1.16B derived: sum of 2 quarters · filed 2013-02-28 | $120.00M derived: sum of 3 quarters · filed 2013-02-28 | $363.00M derived: sum of 4 quarters · filed 2013-02-28 | |
| 2011-12-31 | $988.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$56.00M derived: sum of 2 quarters · filed 2013-02-28 | $187.00M derived: sum of 3 quarters · filed 2013-02-28 | $332.00M 10-K · filed 2013-02-28 | -$334.00M 10-K · filed 2012-02-28 |
| 2011-10-02 | -$1.04B derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | -$801.00M derived: sum of 2 quarters · filed 2011-11-10 | -$656.00M 10-Q · filed 2011-11-10 | ||
| 2011-07-03 | $243.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-11 | $388.00M 10-Q · filed 2011-08-11 | |||
| 2011-04-03 | $145.00M 10-Q · filed 2011-05-12 | ||||
| 2010-12-31 | $683.00M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |